Disclosed are therapeutic compositions and methods for inducing cytotoxic Tcell responses in vitro and in vivo. The therapeutic compositions consist ofantigen presenting cells activated by contact with a polypeptide complexconstructed by joining together a dendritic cell-binding protein and apolypeptide antigen. Also disclosed are expression vectors and systems forproducing the polypeptide complexes.